Apyx Medical Corporation (APYX): Price and Financial Metrics


Apyx Medical Corporation (APYX): $9.44

0.06 (+0.64%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

APYX Stock Summary

  • APYX's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 1,129.56 -- higher than 96.04% of US-listed equities with positive expected earnings growth.
  • The ratio of debt to operating expenses for Apyx Medical Corp is higher than it is for about merely 5.64% of US stocks.
  • With a year-over-year growth in debt of -40.34%, Apyx Medical Corp's debt growth rate surpasses just 9.17% of about US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Apyx Medical Corp are ACRX, SIBN, ATEC, IGC, and CUTR.
  • Visit APYX's SEC page to see the company's official filings. To visit the company's web site, go to apyxmedical.com.

APYX Stock Price Chart Interactive Chart >

Price chart for APYX

APYX Price/Volume Stats

Current price $9.44 52-week high $12.01
Prev. close $9.38 52-week low $2.81
Day low $9.20 Volume 243,900
Day high $9.64 Avg. volume 98,909
50-day MA $10.26 Dividend yield N/A
200-day MA $7.23 Market Cap 323.96M

Apyx Medical Corporation (APYX) Company Bio


Apyx Medical Corporation, a energy technology company, manufactures and sells medical devices in the cosmetic and surgical markets worldwide. It operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). The company develops J-Plasma, a patented plasma-based surgical product for cutting, coagulation, and ablation of soft tissue. It markets and sells Helium Plasma Technology under the Renuvion brand name in the cosmetic surgery market and under the J-Plasma brand name in the hospital surgical market. The company's Renuvion cosmetic technology enables plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue; and the J-Plasma system allows surgeons to operate in eliminating unintended tissue trauma. It also designs, develops, manufactures, and sells electrosurgical and OEM generators and related accessories for medical device manufacturers. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.


APYX Latest News Stream


Event/Time News Detail
Loading, please wait...

APYX Latest Social Stream


Loading social stream, please wait...

View Full APYX Social Stream

Latest APYX News From Around the Web

Below are the latest news stories about Apyx Medical Corp that investors may wish to consider to help them evaluate APYX as an investment opportunity.

Apyx Medical Corporation (APYX) CEO Charlie Goodwin on Q4 2020 Results - Earnings Call Transcript

Apyx Medical Corporation (APYX) Q4 2020 Results Conference Call March 31, 2021 8:00 AM ET Company Participants Charlie Goodwin - President and Chief Executive Officer Tara Semb - Chief Financial Officer Conference Call Participants Matthew O'Brien - Piper Sandler Matt Hewitt - Craig-Hallum Kyle Bauser - Colliers Securities Russell Cleveland...

SA Transcripts on Seeking Alpha | March 31, 2021

Apyx Medical Posts Lower-Than-Expected 4Q Loss, Beats On Revenues

Apyx Medical Corp. reported a smaller-than-feared loss in the fourth quarter. Moreover, revenues topped analysts’ expectations. Shares of the advanced energy technology company rose 2.2% to close at $9.88 on March 30. Apyx Medical (APYX) incurred a loss of $0.04 per share in 4Q, compared to the $0.11 loss per share estimated by analysts. A loss of $0.16 per share was reported in the same quarter last year. Total revenues generated in the quarter increased 36.8% to $11.5 million and came in well ahead of the consensus estimate of $9.62 million. The company’s Advanced Energy segment sales jumped 44% year-over-year, while sales for the OEM segment grew 4%.

Priti Ramgarhia on TipRanks | March 31, 2021

Apyx Medical (NASDAQ:APYX) Shareholders Have Enjoyed A Whopping 503% Share Price Gain

Apyx Medical Corporation ( NASDAQ:APYX ) shareholders have seen the share price descend 15% over the month. But that...

Yahoo | March 27, 2021

Will Apyx Medical (APYX) Report Negative Earnings Next Week? What You Should Know

Apyx (APYX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | March 24, 2021

The Daily Biotech Pulse: Novavax Vaccine Data, ContraFect Secures BARDA Funding, 2 IPOs

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 11) Affimed N.V. (NASDAQ: AFMD ) AngioDynamics, Inc. (NASDAQ: ANGO ) Apyx Medical Corporation (NASDAQ: APYX ) AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO ) Axonics Modulation Technologies, Inc. (NASDAQ: AXNX ) BioAtla, Inc. (NASDAQ: BCAB ) BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX ) Bolt Biotherapeutics, Inc. (NASDAQ: BOLT ) Entera Bio Ltd. (NASDAQ: ENTX ) ( announced positive Phase 2 biomarker data for osteoarthritis drug) Harvard Bioscience, Inc. (NASDAQ: HBIO ) IDEAYA Biosciences, Inc. (NASDAQ: IDYA ) Inari Medical, Inc. (NASDAQ: NARI ) Jounce Therapeutics, Inc. (NASDAQ: JNCE ) Longeveron Inc. (NASDAQ: LGVN ) (announced FDA granting expanded ...

Benzinga | March 12, 2021

Read More 'APYX' Stories Here

APYX Price Returns

1-mo -14.65%
3-mo -4.84%
6-mo 59.46%
1-year 170.49%
3-year 173.62%
5-year 455.29%
YTD 31.11%
2020 -14.89%
2019 30.56%
2018 149.23%
2017 -27.58%
2016 70.95%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 1.0939 seconds.